Tag: shareholder rights

Robbins LLP Reminds CVLT Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action...

Robbins LLP is Investigating Allegations that Commvault Systems, Inc. (CVLT) Misled Investors Regarding its Annualized Recurring Revenue Growth

Dye & Durham Announces Voting Results from Special Meeting of Shareholders

TORONTO, June 9, 2026 /CNW/ - Dye & Durham Limited ("Dye & Durham" or the "Company") (TSX: DND), a leading provider of cloud-based legal practice management software,...

Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, June 08, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Assertio (NASDAQ: ASRT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Zydus.

VRRM INVESTOR ALERT: Verra Mobility Corporation Investors with Substantial Losses Have Opportunity to Lead the Verra Mobility Class Action Lawsuit – RGRD Law

The case alleges Verra Mobility and certain of its top executives made false and/or misleading statements to investors.

SRAD Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Sportradar Group AG Class Action Lawsuit

Robbins LLP is Investigating Allegations that Sportradar Group AG (SRAD) Intentionally Worked with Black-Market Gambling Operators as a Business Strategy

Safirstein Law LLC Announces That A Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP)

RIDGEWOOD, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- RIDGEWOOD, N.J., June 8, 2026 (GLOBE NEWSWIRE) -- Safirstein Law LLC announces that a class action lawsuit has been filed on behalf of shareholders against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP).  

EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUESTIONS MOUNT AHEAD OF THE ELECTION

CHICAGO, June 8, 2026 /PRNewswire/ -- Edward Smolyansky, former Director and Chief Operating Officer of Lifeway Foods, Inc. (NASDAQ: LWAY) and the Company's largest shareholder,...

HELE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Helen of Troy Limited. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Helen of Troy Limited (HELE) Misled Investors Regarding the Ability of Project Pegasus to Improve Efficiency

BMI Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in Badger Meter, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Badger Meter, Inc. (BMI) Concealed Weakening Demand and Deteriorating Near-Term Order Trends

POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm

INVESTOR DEADLINE MONDAY: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.

Globaltech Corp. (OTCQB: GLTK) Update to Shareholders

RENO, Nevada, June 03, 2026 (GLOBE NEWSWIRE) -- Globaltech Corporation (“Globaltech” or the “Company”) (OTCQB: GLTK), a U.S.-based technology holding company, is providing this Update to Shareholders to discuss: (i) how we are managing and operating the Company day to day, (ii) our near-term priorities with a long-term orientation, and (iii) how we responsibly and methodically approach innovation, including AI-enabled products and services.

BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company’s Officers and Directors to Determine if They Violated...

BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if T

Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the...

NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (NYSE:NVO), Altimmune, Inc. (NASDAQ:ALT), SelectQuote, Inc. (NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

STATEMENT – Feds prioritize kids over big tech profits: CMA

SIR Royalty Income Fund Announces June 2026 Distribution

Canada Nickel Completes Upsized Non-Brokered Private Placement of Flow-Through Shares and Provides Corporate Update